结合自动机械外周刺激和跑步机运动,用于帕金森病的步态康复:一个随机对照试验
Claudiane Arakaki Fukuchi1, Vinícius Christianini Moreno1, Carlos Augusto Kalva-Filho1
1Human Movement Research Laboratory (MOVI-LAB), Department of Physical Education, School of Sciences, São Paulo State University (UNESP), Bauru, SP, Brazil.
Clinical biomechanics (Bristol, Avon)
|December 3, 2025
概括
将自动机械外周刺激 (AMPS) 与跑步机炼相结合,对帕金森病 (PD) 患者的步态没有比单独炼更有改善. 虽然这两种干预措施都提高了步骤的长度和速度,但在这项急性研究中,联合方法没有显示出任何额外的益处.
科学领域:
- 神经学 神经学
- 康复医学 康复医学 康复医学
- 运动障碍 运动障碍
背景情况:
- 帕金森病 (PD) 损害了步态,增加了跌倒的风险.
- 跑步机炼可以改善PD步态,但可能无法解决所有问题,例如双重支.
- 自动机械外周刺激 (AMPS) 显示了PD行走康复的潜力.
研究的目的:
- 在患有PD的个体中,研究将AMPS与跑步机运动结合在一起的急性影响.
- 为了确定AMPS是否可以增强PD步行的跑步机训练的好处.
- 评估对步态空间时间参数的影响.
主要方法:
- 15名患有PD的人参加了一项随机对照试验.
- 参与者接受了四次实验室访问:随机顺序的临床评估和三个干预条件 (AMPS,运动,AMPS+运动).
- 在每次干预之前和之后评估了步行状况,每次干预之间有七天的洗期.
主要成果:
- 干预后,步骤长度和步骤速度都显著改善 (p < 0.05).
- 与AMPS+运动条件 (p = 0.031) 相比,单独的运动显示了比AMPS+运动条件 (p = 0.031) 更大的统计学调整后干预步骤速度.
- 联合AMPS和跑步机炼并没有比单独炼更好地改善步态.
结论:
- 虽然AMPS是一种有前途的非药物治疗方法,但其与跑步机运动的急性结合并没有提供额外的益处.
- 进一步的研究可能会探索不同的协议或患者群体,以优化AMPS集成.
- 跑步机运动仍然是一个有效的干预措施,以改善帕金森病的步态参数.
相关概念视频
Parkinson's Disease: Treatment
945
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
945
Parkinson's Disease: Overview
1.7K
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
1.7K


